User profiles for Jonathan W Mant
Jonathan MantProfessor of Primary Care Research Verified email at medschl.cam.ac.uk Cited by 56278 |
[HTML][HTML] Recruitment of ethnic minority patients to a cardiac rehabilitation trial: The Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263]
Background Concerns have been raised about low participation rates of people from minority
ethnic groups in clinical trials. However, the evidence is unclear as many studies do not …
ethnic groups in clinical trials. However, the evidence is unclear as many studies do not …
[HTML][HTML] … failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure …
…, SM Greenfield, MK Davies, RC Davis, JW Mant… - BMC Cardiovascular …, 2007 - Springer
Background Exercise has been shown to be beneficial for selected patients with heart failure,
but questions remain over its effectiveness, cost-effectiveness and uptake in a real world …
but questions remain over its effectiveness, cost-effectiveness and uptake in a real world …
Pro:'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'
JW Mant - Thrombosis and haemostasis, 2008 - thieme-connect.com
A s is well recognised, warfarin is the most effective agent that is available in clinical practice
for preventing the thromboembolic sequelae of atrial fibrillation (AF), particularly stroke (1, 2)…
for preventing the thromboembolic sequelae of atrial fibrillation (AF), particularly stroke (1, 2)…
The use of lipid-lowering drugs across ethnic groups in the secondary prevention of ischaemic heart disease: analysis of cross-sectional surveys in England
A secondary analysis of the Health Surveys for England data was performed to explore the
use of lipid-lowering drug therapy in people with ischaemic heart disease (IHD) across ethnic …
use of lipid-lowering drug therapy in people with ischaemic heart disease (IHD) across ethnic …
WHAT IS THE APPROPRIATE CUT-OFF FOR B NATRIURETIC PEPTIDE TESTING BEFORE ECHOCARDIOGRAPHY IN DIAGNOSIS OF HEART FAILURE?
Purpose: To determine whether B Natriuretic Peptide (BNP) testing is a cost-effective
preliminary to echocardiography in diagnosis of heart failure. Methods: Cost-effectiveness …
preliminary to echocardiography in diagnosis of heart failure. Methods: Cost-effectiveness …
[HTML][HTML] The Stroke Prevention Programme: a programme of research to inform optimal stroke prevention in primary care
Background The management of cardiovascular (CV) risk factors in community populations
is suboptimal. The aim of this programme was to explore the role of three approaches [use of …
is suboptimal. The aim of this programme was to explore the role of three approaches [use of …
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study …
Background Anticoagulants are more effective than antiplatelet agents at reducing stroke
risk in patients with atrial fibrillation, but whether this benefit outweighs the increased risk of …
risk in patients with atrial fibrillation, but whether this benefit outweighs the increased risk of …
[HTML][HTML] Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1
… labeled APS (1 μm mant-APS) was titrated … μm mant-APS and 50 μm PAPSS protein with
increasing concentrations of APS. As mant-APS can be displaced by APS, the fluorescent mant …
increasing concentrations of APS. As mant-APS can be displaced by APS, the fluorescent mant …
Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
… Declared competing interests of authors: David Mant has received BNP assay kits and
technical support from Bayer HealthCare in conducting primary research on the use of BNP for …
technical support from Bayer HealthCare in conducting primary research on the use of BNP for …
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
JW Friedberg, J Sharman… - Blood, The Journal …, 2010 - ashpublications.org
Certain malignant B cells rely on B-cell receptor (BCR)–mediated survival signals. Spleen
tyrosine kinase (Syk) initiates and amplifies the BCR signal. In in vivo analyses of B-cell …
tyrosine kinase (Syk) initiates and amplifies the BCR signal. In in vivo analyses of B-cell …